The article discusses the internal turmoil at OpenAI, a leading artificial intelligence research company, as several key researchers have resigned due to disagreements over the company’s direction and priorities. Sam Altman, the CEO, and Ilya Sutskever, the chief scientist, have clashed over OpenAI’s focus on developing commercial products like ChatGPT versus pursuing more ambitious and potentially transformative AI research. The departures of respected researchers like Dario Amodei and Paul Christiano, who were critical of OpenAI’s shift towards commercialization, have raised concerns about the company’s ability to retain top talent and maintain its cutting-edge research capabilities. The article highlights the challenges faced by AI companies in balancing the pursuit of groundbreaking research with the need to generate revenue and deliver practical applications.